Etiology, classification and diagnosis of congenital biliary dilatation

doi:10.16139/j.1007-9610.2024.02.15

Abstract

Abstract:

The etiology of congenital biliary dilatation (CBD) is still unclear. Currently, abnormal pancreatico-bile duct confluence is the mainstream theory. In terms of classification, Todani classification is the most widely used. On the other hand, Dong's classification which proposed by Dong Jiahong and his colleagues has guiding significance for the selection of surgical methods. CBD is difficult to detect and diagnose because of the poor specificity of clinical symptoms, and it is often necessary to make a preliminary diagnosis based on the medical history, and it is also quite dependent on the assistance of imaging. Serological examination also plays a key role in the diagnosis of CBD because of its convenience and high acceptance. This article reviewed the etiology, classification and diagnosis of CBD.

Key words: Congenital biliary dilatation(CBD), Congenital choledochal cyst, Imaging diagnosis, Serological diagnosis

CLC Number:

R657.4

GAO Zhenhua, WU Shuodong. Etiology, classification and diagnosis of congenital biliary dilatation[J]. Journal of Surgery Concepts & Practice, 2024, 29(02): 182-185.

References 27

[1]	TEN HOVE A, DE MEIJER V E, et al. Meta-analysis of risk of developing malignancy in congenital choledochal malformation[J]. Br J Surg, 2018, 105(5):482-490. doi: 10.1002/bjs.10798 pmid: 29480528
[2]	MACHADO N O, CHOPRA P J, AL-ZADJALI A, et al. Choledochal cyst in adults: etiopathogenesis, presentation, management, and outcome-case series and review[J]. Gastroenterol Res Pract, 2015,2015:602591.
[3]	BABBITT D P. Congenital choledochal cysts: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb[J]. Ann Radiol(Paris), 1969, 12(3):231-240.
[4]	YONEM O, BAYRAKTAR Y. Clinical characteristics of Caroli’s syndrome[J]. World J Gastroenterol, 2007, 13(13):1934-1937.
[5]	MITRA S, RENNIE J. Neonatal jaundice: aetiology, diagnosis and treatment[J]. Br J Hosp Med (Lond), 2017, 78(12):699-704. doi: 10.12968/hmed.2017.78.12.699 pmid: 29240507
[6]	VISSER B C, SUH I, WAY L W, et al. Congenital choledochal cysts in adults[J]. Arch Surg, 2004, 139(8):855-860.
[7]	SOARES K C, ARNAOUTAKIS D J, KAMEL I, et al. Choledochal cysts: presentation, clinical differentiation, and management[J]. J Am Coll Surg, 2014, 219(6):1167-1180.
[8]	董家鸿, 曾建平, 冯晓彬. 胆管扩张症临床分型和外科治疗的实践与思考[J]. 中华消化外科杂志, 2017, 16(8):775-776.
	DONG J H, ZENG J P, FENG X B. Clinical classification and surgical treatment of biliary dilatation: application and consideration[J]. Chin J Dig Surg, 2017, 16(8):775-776.
[9]	GADELHAK N, SHEHTA A, HAMED H. Diagnosis and management of choledochal cyst: 20 years of single center experience[J]. World J Gastroenterol, 2014, 20(22):7061-7066.
[10]	ISHIBASHI H, SHIMADA M, KAMISAWA T, et al. Japanese clinical practice guidelines for congenital bi-liary dilatation[J]. J Hepatobiliary Pancreat Sci, 2017, 24(1):1-16.
[11]	王长青, 程丽丽, 赵维安. 超声对先天性胆总管囊状扩张症的诊断价值[J]. 陕西医学杂志, 2007, 36(6):758.
	WANG C Q, CHENG L L, ZHAO W A. The diagnostic value of ultrasound in congenital cystic dilation of the common bile duct[J]. Shaanxi Med J, 2007, 36(6):758.
[12]	KATABATHINA V S, KAPALCZYNSKI W, DASYAM A K, et al. Adult choledochal cysts: current update on classification, pathogenesis, and cross-sectional imaging findings[J]. Abdom Imaging, 2015, 40(6):1971-1981. doi: 10.1007/s00261-014-0344-1 pmid: 25588714
[13]	SAITO T, TERUI K, MITSUNAGA T, et al. Significance of imaging modalities for preoperative evaluation of the pancreaticobiliary system in surgery for pediatric choledochal cyst[J]. J Hepatobiliary Pancreat Sci, 2016, 23(6):347-352. doi: 10.1002/jhbp.347 pmid: 26994400
[14]	FUMINO S, ONO S, KIMURA O, et al. Diagnostic impact of computed tomography cholangiography and magnetic resonance cholangiopancreatography on pancreaticobiliary maljunction[J]. J Pediatr Surg, 2011, 46(7):1373-1378. doi: 10.1016/j.jpedsurg.2011.01.026 pmid: 21763837
[15]	KAMISAWA T, ANDO H, HAMADA Y, et al. Diagnostic criteria for pancreaticobiliary maljunction 2013[J]. J Hepatobiliary Pancreat Sci, 2014, 21(3):159-161. doi: 10.1002/jhbp.57 pmid: 24307541
[16]	徐贺龙, 岳平, 李汛. 先天性胆管扩张症的诊疗进展[J]. 现代消化及介入诊疗, 2019, 24(11):1215-1217.
	XU H L, YUE P, LI X. Progress in diagnosis and treatment of congential biliary dilatation[J]. Mod Dig Intervent, 2019, 24(11):1215-1217.
[17]	郑佳辰. 基于甲基化芯片和生物信息学分析的先天性胆管扩张症潜在差异甲基化位点及相关基因分子机制研究[D]. 广东: 汕头大学, 2021.
	ZHENG J C. Potential differential methylation sites and related gene molecular mechanisms in congenital cholangiectasis based on methylation chip and bioinformatics analysis[D]. Guangdong: Shantou Univ, 2021.
[18]	RUPPERT M, FRANZ M, SARATSIS A, et al. Hangover links nuclear RNA signaling to cAMP regulation via the phosphodiesterase 4D ortholog dunce[J]. Cell Rep, 2017, 18(2):533-544.
[19]	PAL S, PORWAL K, KHANNA K, et al. Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: a comparative study with human parathyroid hormone[J]. Bone, 2019,123:28-38.
[20]	ROSKAMS T, CAMPOS R V, DRUCKER D J, et al. Reactive human bile ductules express parathyroid hormone-related peptide[J]. Histopathology, 1993, 23(1):11-19. pmid: 8365711
[21]	PLAZA-DIAZ J, GOMEZ-LLORENTE C, FONTANA L, et al. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics[J]. World J Gastroenterol, 2014, 20(42):15632-15649.
[22]	MALHI H, GORES G J. Cellular and molecular mechanisms of liver injury[J]. Gastroenterol, 2008, 134(6):1641-1654.
[23]	MING G, GUO W, CHENG Y, et al. Identification and evaluation of fructose-bisphosphate aldolase B as a potential diagnostic biomarker in choledochal cysts patients: a quantitative proteomic analysis[J]. Transl Pediatr, 2021, 10(8):2083-2094. doi: 10.21037/tp-21-336 pmid: 34584879
[24]	吴宙光, 王斌, 陈子民, 等. 异性烯醇化酶和X链锁凋亡抑制蛋白在先天性胆管扩张症发病中的作用[J]. 现代肿瘤医学, 2019, 27(5):833-835.
	WU Z G, WANG B, CHEN Z M, et al. Heterosexual enolase and X-linked inhibitor of apoptosis protein in the pathogenesis of congenital biliary dilatation[J]. J Mod Oncol, 2019, 27(5):833-835.
[25]	吴宙光, 王斌, 程珍, 等. 先天性胆管扩张症患者转化生长因子β1、白细胞介素-32的表达水平及临床相关性分析[J]. 国际检验医学杂志, 2021, 42(5):541-544.
	WU Z G, WANG B, CHENG Z, et al. Expression levels of transformed growth factor β1 and interleukin-32 and clinical correlation analysis in patients with congenital biliary dilation[J]. Int J Lab Med, 2021, 42(5):541-544.
[26]	中华医学会外科学分会胆道外科学组. 胆管扩张症诊断与治疗指南(2017版)[J]. 中华消化外科杂志, 2017, 16(8):767-774.
	Section of Biliary Surgery Branch of Surgery Chinese Medical Association. Guideline for the diagnosis and treatment for biliary dilatation (2017 edition)[J]. Chin J Dig Surg, 2017, 16(8):767-774.
[27]	KUYAMA H, MORINE Y, SHIMADA M, et al. Carcinogenic potential of biliary epithelium of congenital choledochal cyst model in rats: a special reference to HDAC expression[J]. Hepatogastroenterology, 2014, 61(131):795-801.